Item request has been placed!
×
Item request cannot be made.
×
Processing Request
mRNA for the EAAC1 subtype of glutamate transporter is present in neuronal dendrites in vitro and dramatically increases in vivo after a seizure.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Author(s): Ross JR;Ross JR; Porter BE; Buckley PT; Eberwine JH; Robinson MB
- Source:
Neurochemistry international [Neurochem Int] 2011 Feb; Vol. 58 (3), pp. 366-75. Date of Electronic Publication: 2010 Dec 24.
- Publication Type:
Journal Article; Research Support, N.I.H., Extramural
- Language:
English
- Additional Information
- Source:
Publisher: Pergamon Press Country of Publication: England NLM ID: 8006959 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-9754 (Electronic) Linking ISSN: 01970186 NLM ISO Abbreviation: Neurochem Int Subsets: MEDLINE
- Publication Information:
Original Publication: Oxford [Elmsford, N. Y.] Pergamon Press.
- Subject Terms:
- Abstract:
The neuronal Na(+)-dependent glutamate transporter, excitatory amino acid carrier 1 (EAAC1, also called EAAT3), has been implicated in the control of synaptic spillover of glutamate, synaptic plasticity, and the import of cysteine for neuronal synthesis of glutathione. EAAC1 protein is observed in both perisynaptic regions of the synapse and in neuronal cell bodies. Although amino acid residues in the carboxyl terminal tail have been implicated in the dendritic targeting of EAAC1 protein, it is not known if mRNA for EAAC1 may also be targeted to dendrites. Sorting of mRNA to specific cellular domains provides a mechanism by which signals can rapidly increase translation in a local environment; this form of regulated translation has been linked to diverse biological phenomena ranging from establishment of polarity during embryogenesis to synapse development and synaptic plasticity. In the present study, EAAC1 mRNA sequences were amplified from dendritic samples that were mechanically harvested from low-density hippocampal neuronal cultures. In parallel analyses, mRNA for histone deacetylase 2 (HDAC-2) and glial fibrillary acidic protein (GFAP) was not detected, suggesting that these samples are not contaminated with cell body or glial mRNAs. EAAC1 mRNA also co-localized with Map2a (a marker of dendrites) but not Tau1 (a marker of axons) in hippocampal neuronal cultures by in situ hybridization. In control rats, EAAC1 mRNA was observed in soma and proximal dendrites of hippocampal pyramidal neurons. Following pilocarpine- or kainate-induced seizures, EAAC1 mRNA was present in CA1 pyramidal cell dendrites up to 200μm from the soma. These studies provide the first evidence that EAAC1 mRNA localizes to dendrites and suggest that dendritic targeting of EAAC1 mRNA is increased by seizure activity and may be regulated by neuronal activity/depolarization.
(Copyright © 2010 Elsevier Ltd. All rights reserved.)
- References:
Neuron. 2008 May 22;58(4):472-97. (PMID: 18498731)
Neurosci Lett. 1999 Dec 10;276(3):157-60. (PMID: 10612629)
Glia. 1999 Aug;27(2):129-42. (PMID: 10417812)
J Neurosci. 2002 Aug 1;22(15):6372-9. (PMID: 12151515)
J Neurophysiol. 1997 Apr;77(4):1924-38. (PMID: 9114245)
J Cereb Blood Flow Metab. 2006 Nov;26(11):1419-30. (PMID: 16538232)
Neuroreport. 1996 Feb 29;7(3):705-9. (PMID: 8733726)
Arch Gen Psychiatry. 2006 Jul;63(7):769-76. (PMID: 16818866)
Mol Pharmacol. 1996 Mar;49(3):465-73. (PMID: 8643086)
Neurosci Lett. 2001 Oct 5;311(3):161-4. (PMID: 11578819)
Neuron. 1996 Mar;16(3):675-86. (PMID: 8785064)
J Neurosci. 1997 Dec 15;17(24):9492-505. (PMID: 9391005)
Am J Physiol. 1996 Jan;270(1 Pt 1):C67-75. (PMID: 8772431)
Biotechniques. 1996 Apr;20(4):584-91. (PMID: 8800675)
Cell. 2001 Nov 16;107(4):489-99. (PMID: 11719189)
Neurochem Int. 2007 Nov-Dec;51(6-7):333-55. (PMID: 17517448)
J Cell Sci. 2006 Sep 15;119(Pt 18):3776-87. (PMID: 16959903)
Trends Cell Biol. 2009 Sep;19(9):465-74. (PMID: 19716303)
Brain Res. 2008 Jan 16;1189:236-46. (PMID: 18062938)
Epilepsia. 2002 Mar;43(3):211-8. (PMID: 11906504)
Trends Cell Biol. 2007 Jul;17(7):343-52. (PMID: 17644382)
Brain. 2002 Jan;125(Pt 1):32-43. (PMID: 11834591)
J Neurosci. 2001 Nov 1;21(21):8328-38. (PMID: 11606620)
Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):10800-4. (PMID: 7971965)
J Neurosci. 2006 Oct 11;26(41):10461-71. (PMID: 17035530)
J Neurosci. 2006 Aug 16;26(33):8537-48. (PMID: 16914680)
Neuron. 1994 Sep;13(3):713-25. (PMID: 7917301)
Anat Embryol (Berl). 1998 Jul;198(1):13-30. (PMID: 9683064)
J Neurosci. 2006 Dec 20;26(51):13390-9. (PMID: 17182790)
Brain Res Mol Brain Res. 1996 Apr;37(1-2):297-303. (PMID: 8738164)
Neuroscience. 2007 Nov 30;150(1):31-9. (PMID: 17928157)
Cereb Cortex. 1998 Mar;8(2):108-16. (PMID: 9542890)
EMBO J. 1997 Jul 1;16(13):3822-32. (PMID: 9233792)
Trends Neurosci. 2010 Apr;33(4):173-82. (PMID: 20303187)
Trends Neurosci. 2004 Jul;27(7):370-7. (PMID: 15219735)
J Neurochem. 2006 Aug;98(4):1007-18. (PMID: 16800850)
J Neurosci. 2004 Jul 28;24(30):6842-52. (PMID: 15282290)
Genes Dev. 2003 Mar 1;17(5):638-53. (PMID: 12629046)
Neuron. 2004 Sep 30;44(1):59-73. (PMID: 15450160)
J Biol Chem. 1998 Oct 30;273(44):28921-30. (PMID: 9786895)
Brain Res Mol Brain Res. 1999 Feb 19;65(1):112-23. (PMID: 10036313)
Proc Natl Acad Sci U S A. 2001 Nov 6;98(23):13037-42. (PMID: 11606784)
BMC Neurosci. 2006 Feb 17;7:17. (PMID: 16503994)
Neuroscientist. 2004 Oct;10(5):456-66. (PMID: 15487031)
Arch Gen Psychiatry. 2006 Jul;63(7):778-85. (PMID: 16818867)
Electroencephalogr Clin Neurophysiol. 1972 Mar;32(3):281-94. (PMID: 4110397)
J Neurochem. 2001 Feb;76(3):892-900. (PMID: 11158261)
Neuroscientist. 2004 Dec;10(6):495-500. (PMID: 15534035)
Nat Neurosci. 2002 Feb;5(2):155-61. (PMID: 11788834)
J Neurosci. 2002 Dec 15;22(24):10643-52. (PMID: 12486157)
Proc Natl Acad Sci U S A. 2000 Oct 10;97(21):11545-50. (PMID: 11027353)
Learn Mem. 2007 Jun 11;14(6):433-45. (PMID: 17562895)
J Neurosci. 2003 Mar 15;23(6):2040-8. (PMID: 12657662)
J Neurochem. 1997 Apr;68(4):1564-70. (PMID: 9084427)
Nat Neurosci. 2006 Jan;9(1):119-26. (PMID: 16311588)
Curr Opin Neurobiol. 2007 Jun;17(3):289-97. (PMID: 17475474)
Neuron. 2003 Oct 9;40(2):347-59. (PMID: 14556713)
Handb Exp Pharmacol. 2006;(175):251-75. (PMID: 16722240)
J Comp Neurol. 2000 Mar 13;418(3):255-69. (PMID: 10701825)
Science. 1997 Jun 13;276(5319):1699-702. (PMID: 9180080)
Cell. 2008 Oct 31;135(3):401-6. (PMID: 18984149)
Prog Neurobiol. 2001 Sep;65(1):1-105. (PMID: 11369436)
J Neurosci. 1985 Aug;5(8):2240-53. (PMID: 2991484)
J Neurosci. 2009 Nov 18;29(46):14581-95. (PMID: 19923291)
J Neurosci. 1998 Jan 1;18(1):251-65. (PMID: 9412505)
- Grant Information:
P30 HD026979 United States HD NICHD NIH HHS; R01 NS056222 United States NS NINDS NIH HHS; R37 AG009900 United States AG NIA NIH HHS; R01 NS056222-04 United States NS NINDS NIH HHS; R37 AG009900-20 United States AG NIA NIH HHS; R01 HD060132-17 United States HD NICHD NIH HHS; R01 HD060132 United States HD NICHD NIH HHS; R01 AG009900 United States AG NIA NIH HHS; F31 NS049690-05 United States NS NINDS NIH HHS; P30 HD26979 United States HD NICHD NIH HHS; F31 NS049690 United States NS NINDS NIH HHS; R01 AG9900 United States AG NIA NIH HHS; P30 HD026979-21 United States HD NICHD NIH HHS
- Accession Number:
0 (Excitatory Amino Acid Transporter 3)
0 (RNA, Messenger)
0 (Slc1a1 protein, rat)
3KX376GY7L (Glutamic Acid)
- Publication Date:
Date Created: 20101228 Date Completed: 20111227 Latest Revision: 20211020
- Publication Date:
20240829
- Accession Number:
PMC3040252
- Accession Number:
10.1016/j.neuint.2010.12.012
- Accession Number:
21185901
No Comments.